Trial Profile
A repeated oral dose study in healthy Japanese male subjects and a multi-center, placebo-controlled, randomized, double-blinded, parallel-group comparative study in Japanese osteoarthritis patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs ONO 4474 (Primary)
- Indications Musculoskeletal pain
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 08 Jul 2019 Efficacy, safety and tolerability results (n=110) were published in the Journal of Clinical Pharmacology.
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 05 Mar 2018 New trial record